doi: 10.1016/j.eprac.2021.04.001 Summary Keywords semaglutide, overweight, obese, meta-analysis, subgroup Citation Zhang R, Hou Q, Li B, Deng L, Yang Y, Li T, Yao X, Yang L, Lin X, Liao Y, Wang L, Liu Y, Tan J, Wan Z and Shuai P (2023) Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Its still in the early days, but the connection is promisingand its an exciting area for future research
The existence of an effective medication seems to have snapped obesity from a perceived personal failure into the category of treatable disease
If you and your partner are considering semaglutide, prepare for the occasional debate over the last veggie stickbut know that the health rewards are worth it
Health-Related Outcomes General health status and quality of life was assessed by the Short Form health survey (SF-36)
Cefalea transitoria o sensibilidad digestiva en sujetos sensibles